Amantadine and rimantadine for influenza A in children and the elderly-Reference-Cited by-同舟云学术

Amantadine and rimantadine for influenza A in children and the elderly

Published:2014-11-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Alves Galvão Márcia G¹,Rocha Crispino Santos Marilene Augusta¹,Alves da Cunha Antonio JL²

Affiliation:

1. Municipal Secretariat of Health; Avenida Ayrton Senna, 250/ 205 Barra da Tijuca. Alfa Barra 1 Rio de Janeiro RJ Brazil 22793-000

2. School of Medicine, Federal University of Rio de Janeiro; Department of Pediatrics; Av. Carlos Chagas Filho, 373 Edificio do CCS - Bloco K - 2o. andar, Sala K49 Rio de Janeiro Rio de Janeiro Brazil 21941-902

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002745.pub4/fullpdf

Reference274 articles.

1. Effectiveness of rimantadine prophylaxis of children within families;Clover;American Journal of Diseases of Children,1986

2. Effect of rimantadine on the immune response to influenza A infections;Clover;Journal of Medical Virology,1991

3. Rimantadine prophylaxis in children: a follow up study;Crawford;Pediatric Infectious Disease Journal,1988

4. A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness;Finklea;American Journal of Epidemiology,1967

5. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population;Gravenstein;Journal of the American Medical Directors Association,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. About the global strategy for the prevention of influenza in 2019–2030;Oral and General Health;2024-08-31

2. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08

3. Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2024-04-05

4. An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil;Science Advances;2024-02-23

5. Naturally Occurring Isorhamnetin Glycosides as Potential Agents Against Influenza Viruses: Antiviral and Molecular Docking Studies;ACS Omega;2023-12-08